F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump - News Summed Up

F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump


The Food and Drug Administration has granted emergency authorization for the experimental antibody treatment given to President Trump shortly after he was diagnosed with Covid-19, giving doctors another option to treat Covid-19 patients as cases across the country continue to rise. A similar treatment, made by Eli Lilly, was given emergency approval earlier this month. The emergency authorization for Regeneron’s drug is limited in scope: It is for people 12 and over who have tested positive for the coronavirus and who are at high risk for developing severe Covid-19. Evidence so far suggests that antibody treatments work best early in the course of the disease, before the virus has gained a foothold in the body. Like Eli Lilly’s treatment, Regeneron’s is not authorized for use in people who are hospitalized or who need oxygen.


Source: New York Times November 22, 2020 01:03 UTC



Loading...
Loading...
  

Loading...